Staffing and Research Support Payments. CFFT will make the payments to Vertex specified below during 2004 and 2005 in support of the Research Program under this Agreement. [***] [***] [***] [***] [***] [***] Total $ 21.281 Vertex will dedicate a minimum average [***] during its term, [***] Unless otherwise agreed in writing by CFFT, from and after the earlier of the date upon which Vertex notifies CFFT of its selection of a Primary and an Alternate Program, Vertex will devote [***] to the Alternate Program, and will apply [***]. Subject to the foregoing requirements, the research support specified above can be allocated as Vertex may determine in good faith between in-house and outside resources, between the Primary Program and the Alternative Program, and between and among individual budget line items.
Appears in 4 contracts
Samples: Development and Commecialization Agreement (Royalty Pharma PLC), Development and Commecialization Agreement (Royalty Pharma PLC), Confidential Treatment Requested (Vertex Pharmaceuticals Inc / Ma)
Staffing and Research Support Payments. CFFT will make the payments to Vertex specified below during 2004 and 2005 in support of the Research Program under this Agreement. [***] [***] [***] [***] [***] [***] Total $ $21.281 Vertex will dedicate a minimum average [***] during its term, [***] Unless otherwise agreed in writing by CFFT, from and after the earlier of the date upon which Vertex notifies CFFT of its selection of a Primary and an Alternate Program, Vertex will devote [***] to the Alternate Program, and will apply [***]. Subject to the foregoing requirements, the research support specified above can be allocated as Vertex may determine in good faith between in-house and outside resources, between the Primary Program and the Alternative Program, and between and among individual budget line items.
Appears in 2 contracts
Samples: Research, Development and Commecialization Agreement (Vertex Pharmaceuticals Inc / Ma), Development and Commecialization Agreement (Vertex Pharmaceuticals Inc / Ma)
Staffing and Research Support Payments. CFFT will make the payments to Vertex specified below during 2004 and 2005 in support of the Research Program under this Agreement. [***] [***] [***] [***] [***] [***] Total $ 21.281 Vertex will dedicate a minimum average [***] during its term, [***] Unless otherwise agreed in writing by CFFT, from and after the earlier of the date upon which Vertex notifies CFFT of its selection of a Primary and an Alternate Program, Vertex will devote [***] to the Alternate Program, and will apply [***]. Subject to the foregoing requirements, the research support specified above can be allocated as Vertex may determine in good faith between in-house and outside resources, between the Primary Program and the Alternative Program, and between and among individual budget line items.. Confidential Treatment Requested by Royalty Pharma plc Pursuant to 17 C.F.R. Section 200.83
Appears in 1 contract
Samples: Research, Development and Commecialization Agreement (Royalty Pharma PLC)